Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

Journal of Endocrinological Investigation

Volumn 19, Issue 1, 1996, Pages 25-29

  Arvat, E ^a   Gianotti, L ^a   Ramunni, J ^a   DiVito, L ^a   Deghenghi, R ^b   Camanni, F ^a   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

Atenolol; GH; Hexarelin; Salbutamol

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; SALBUTAMOL; SOMATOSTATIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SOMATOSTATIN RELEASE;

EID: 0029914481     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347854     Document Type: Article

References (33)

1. Ghigo E. Neurotransmitter control of growth hormone secretion. In: De la Cruz L.F. (Ed.). Regulation of growth hormone and somatic growth. Excerpta Medica, Amsterdam, 1992, p. 103.
2. Chihara K., Kodama H., Kaji H., Kashio Y., Okimara Y., Abe H., Fujita T. Augmentation by propranolol of growth hormone releasing hormone (1-44) NH2-induced growth hormone release in normal short and normal children. J. Clin. Endocrinol. Metab. 67: 229, 1985.
3. Mauras N., Blizzard R.M., Thorner M.O., Rogol A.D. Selective B1 adrenergic receptor blockade with atenolol enhances growth hormone-releasing hormone-mediated growth hormone release in man. Metabolism 36: 369, 1987.
4. Martha P.M. Jr, Blizzard R.M., Rogol A.D. Atenolol enhanced growth hormone release to exogenous nocturnal growth hormone secretion in boys with constitutional delay of growth. Pediatr. Res. 23: 393, 1988.
5. Ghigo E., Bellone J., Arvat E., Mazza E., Cella S.G., Brambilla F., Muller E.E., Camanni F. Effects of alpha and beta adrenergic agonists and antagonists on growth hormone secretion in man. J. Neuroendocrinol. 2: 473, 1990.
6. Ghigo E., Arvat E., Gianotti L., Ramunni J., Maccario M., Camanni F. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin. Endocrinol. (Oxf.) 40: 799, 1994.
7. Arvat E., Ramunni J., Gianotti L., Di Vito L., Maccario M., Camanni F., Ghigo E. Interaction of salbutamol and galanin on both basal and GHRH-stimulated GH secretion in humans. J. Endocrinol. Invest. 18: 324, 1995.
8. Bowers C.Y., Momany F.A., Reynolds G.A., Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537, 1984.
9. Clark R.G., Carlsson M.S., Trojnar J., Robinson I.C.A.F. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J. Neuroendocrinol. 1: 252, 1989.
10. Ilson B.E., Jorkasky O.K., Cumow R.T., Stote R.M. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J. Clin. Endocrinol. Metab. 69: 212, 1989.
11. Bowers C.Y., Reynolds G.A., Durham D., Barrera C.M., Pezzoli S.S., Thorner M.O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab. 70: 975, 1990.
12. Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J. Clin. Endocrinol. Metab. 78: 693, 1994.
13. Momany F., Bowers C.Y., Reynolds G.A., Hong A., Newlander K. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 114: 1531, 1984.
14. Bowers C.Y., Sartor A.O., Reynolds G.A., Badger T.M. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128: 2027, 1991.
15. Badger T.M., Millard W.Y., McCormik G.F., Bowers C.Y., Martin J.B. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 115: 1432, 1984.
16. Sartor O., Bowers C.Y., Chang D. Parallel studies of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rat primary pituitary cell monolayer culture. Endocrinology 116: 952, 1985.
17. Cheng K., Chan W.W.S., Barreto A., Convey E.M., Smith R.G. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary cell culture. Endocrinology 124: 2791, 1989.
18. Goth M.I., Lyons C.E., Canny B.Y., Thorner M.O. Pituitary adenilate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130: 939, 1992.
19. Codd E.E., Shu A.Y.L, Walker R.F. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28: 1139, 1989.
20. Veeraragan K., Sethumadhavan K., Bowers C.Y. Growth hormone-releasing peptide (GHRP) binding to porcine anterior-pituitary and hypothalamic membranes. Life Sci. 50: 1149, 1992.
21. Deghenghi R., Boutignon F., Wuthrich P., Lenaerts V., Imbimbo B., Lucchelli P.E., Locatelli V., Battisti C., Cananzi M., Muller E.E. GH releasing properties of hexarelin (EP 23905) International Symposium on Growth Hormone II: Basic and Clinical Aspects. Tarpon Springs, Florida, 1992, p. 31, (Abstract).
22. Conley L.C., Giustina A., Imbimbo B.P., Stagg L.C., Deghenghi R., Weherenberg W.B. Hexarelin [His-D-2-Methyl-Trp-Ala-Trp-D-Phe-Lys-NH2], a novel GH-releasing peptide, is biologically active in male and female rats. Endocrine 2: 691, 1994.
23. Deghenghi R., Cananzi M., Torsello A., Battisti C., Muller E.E., Locatelli V. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 54: 1321, 1994.
24. Arvat E., Gianotti L., Di Vito L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 67: 51, 1995.
25. Maccario M., Arvat E., Procopio M., Gianotti L., Grottoli S., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 1: 134, 1995.
26. Penalva A., Pombo M., Carballo A., Barreiro J., Casanueva F.F., Dieguez C. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Clin. Endocrinol. (Oxf.) 38: 87, 1993.
27. Malozowsky S., Hao E.N., Ren S.G., Marin G., Liu L., Southers J.L., Merriam G.R. Growth hormone (GH) responses to the hexapeptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non GHRH-mediated responses. J. Clin. Endocrinol. Metab. 73: 314, 1991.
28. Samols E., Weir G.C., Ranseur R., Day J.A., Patel Y.C. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyperglycemic sulfonamides. Metabolism 9(Suppl 1): 1219, 1978.
29. Krieg R.J., Perkins S.N., Johnson J.H., Rogers J.P., Arimura A., Cronin M.J. B Adrenergic stimulation of growth hormone (GH) release in vivo and subsequent inhibition of GH releasing factor-induced GH secretion. Endocrinology 122: 531, 1988.
30. Richardson S.B., Twente S. Inhibition of hypothalamic somatostatin release by β adrenergic antagonist. Endocrinology 126: 1043, 1990.
31. Kelijman M., Frohman L. β-adrenergic modulation of growth hormone (GH) autofeedback on sleep-associated and pharmacologically induced GH secretion. J. Clin. Endocrinol. Metab. 69: 1187, 1989.
32. Arosio M., Losa M., Bazzoni N., Bochicchio D., Palmieri E., Nava C., Faglia G. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulation in normal subjects. Acta Endocrinol. (Copenh.) 122: 1, 1990.
33. Hao E.H., Malozowsky S., Ren S.G., Marin G., Southers J., Merriam G. A comparison of the effects of GH-releasing hormone (GHRH) and GH-releasing peptide (GHRP) on GH and somatostatin (SRIF) release. Proc. 70th Ann. Meet. Endocr. Soc. New Orleans, Louisiana, p. 304, 1988 (abstract).